PG
IQV icon

Prostatis Group’s IQVIA IQV Stock Holding History

Prostatis Group’s Portfolio IQV Stock Details IQV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$214K Buy
+1,109
New +$193K 0.05% 180

Other funds holding IQV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Prostatis Group's IQV Position: Q2 2026 in Review

Prostatis Group opened a new position in IQVIA (IQV) in Q2 2026: 1,109 shares worth $214K. The stake represents 0.05% of the portfolio and ranks #180 among its holdings.

1,085 funds tracked by Wall St. Rank hold IQV as of Q2 2026.

  • Prostatis Group held 1,109 shares of IQVIA worth $214K as of Q2 2026.
  • IQVIA was a new Prostatis Group position in Q2 2026.
  • IQVIA made up 0.05% of Prostatis Group's portfolio in Q2 2026, its #180 holding.
  • 1,085 funds tracked by Wall St. Rank held IQVIA as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.